Mark Koeniguer

Mark Koeniguer has a long and varied career in the medical technology industry. Starting in 1988, they began their career at GE Healthcare, where they held various roles in sales and marketing leadership, commercial management, and global operations. In 2001, they joined Stereotaxis Inc as Global Vice President Marketing and Sales, where they were responsible for driving the FDA approval process for the first to market system and disposables. In 2004, they moved to R2 Technology, Inc. as Executive Vice President, Global Marketing and Sales, and the company was acquired by Hologic Inc. in 2006 for $220M. In 2007, they joined Ziosoft Inc. as Chief Operating Officer, North America and Europe. In 2009, they moved to Estech as Vice President Global Marketing, Sales and Commercial Operations, and the company was acquired in December 2013 by Atricure Inc. In 2014, they joined Cardioptimus as CEO Consultant, and in 2016 they joined Volpara Solutions as Chief Commercial Officer and President US. In 2021, they moved to Riverain Technologies as Chief Commercial Officer (CCO) and in 2022 they joined ScreenPoint Medical as Chief Executive Officer.

Mark Koeniguer obtained their Bachelor of Science in Finance from the University of Iowa in 1988. Mark then went on to pursue a dual MBA from the Wisconsin School of Business and the University of Wisconsin-Madison, which they completed in 2000.